September 6, 2023
- August 16, 2023 - Analytical and Clinical Validation of Biomarkers for Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Optional). See NOFO PAR-23-258.
National Institute on Aging (NIA)
The purpose of this Notice is to inform potential applicants that the National Institute on Aging (NIA) will hold two informational pre-application webinars for Notice of Funding Opportunity (NOFO) PAR-23-258, “Analytical and Clinical Validation of Biomarkers for Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Optional)" on Thursday, September 14, at 1:00 PM ET and Thursday, September 21, at 1:00 PM ET.
The overarching goal of PAR-23-258 is to accelerate the establishment of effective and reliable biomarkers of AD/ADRD for use in medical product development, clinical trials, and/or clinical practice. The NOFO supports rigorous analytical and/or clinical validation within a specified Context of Use (COU), and utilizes the milestone-driven U01 Research Project-Cooperative Agreements funding mechanism.
Webinar Information
- Dates: September 14, 2023 and September 21, 2023
- Time: 1:00 PM - 2:00 PM ET.
Prospective applicants are required to register in advance using the registration link: Zoom Registration Link. Call-in information will be provided once registration is received. The webinar is optional and is not required for application submission.
Submitting Questions for the Webinar
Prospective applicants are strongly encouraged to submit their questions or comments to [email protected] in advance of the webinar. Please indicate "U01 Biomarkers Validation Pre-application Webinar" in the subject line of the email.
Yuan Luo, Ph.D.
Division of Neuroscience (DN)
National Institute on Aging (NIA)
Phone: 202-510-2567
Email: [email protected]
and Human Services (HHS)
